Champignon Brands Updates Investors on Changes at the Top Post published:November 24, 2020 Post category:Press Release
MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines Post published:November 24, 2020 Post category:Press Release
ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round Post published:November 23, 2020 Post category:Press Release
Novamind Closes Oversubscribed CAD$10 Million Private Placement Post published:November 23, 2020 Post category:Press Release
Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market Post published:November 20, 2020 Post category:Press Release
Mind Cure Announces Closing of Oversubscribed $3.6 Million Offering Post published:November 19, 2020 Post category:Press Release
Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health Post published:November 19, 2020 Post category:Press Release
NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight Loss Post published:November 19, 2020 Post category:Press Release
Nova Mentis Life Science Announces Receipt of Pilz Shareholder Approval Post published:November 18, 2020 Post category:Press Release
Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders Post published:November 18, 2020 Post category:Press Release